Key Metrics for Citius Pharmaceuticals, Inc.
Valuation
Valuation Multiples
Enterprise Value Multiples
Stock Price (FY-end)↓-97.6% -$50
$1
Market Cap↓-99.8% -$5.50B
$14M
Phase 1: currency selection stored in the URL. Conversion ships in Phase 2 (see ADR-0003).
Phase 1: currency selection stored in the URL. Conversion ships in Phase 2 (see ADR-0003).